Currently Recruiting Clinical Trials
COMBINE 1 Type 2 Diabetes Study
COMBINE is a global programme of clinical studies to investigate how well a new combination therapy taken once weekly, controls blood sugar levels in people with diabetes. The study will be conducted over a period of 14 months.
You may be eligible to participate if you:
- have Type 2 diabetes mellitus for at least 6 months
- are at least 18 years of age
- have HbA1c between 7.0 -10.0% inclusive
- have a BMI of no more than 40.0 kg/m2
- are tech savvy
- are treated with basal insulin once daily or twice daily (20‑80 units/day for at least 90 days)
To find out more, please contact the Study Coordinators:
- Fahriya Zandari Ext: 421 52877 Email: [email protected]
- Jo Chambers Ext: 421 52884 Email: [email protected]
Cytomegalovirus (CMV) vaccine clinical trial
The Barwon Health Clinical Trial Unit is looking for healthy women aged between 16 and 40 years of age to participate in study to evaluate an investigational CMV Vaccine.
Cytomegalovirus (CMV) infection is common. CMV infection in children and adults rarely causes symptoms, however CMV infection pregnant mothers can result in infection of babies in their mother's womb or at the time of birth and can result in significant lifelong disability.
Barwon Health Director of Infectious Diseases, Professor Eugene Athan, is conducting the clinical trial.
You may be eligible to participate if you:
- Are between 16 and 40 years of age,
- Are in general good health
- If you are a female, have or anticipate having direct exposure to at least one child 5 years of age or younger, either in the home, socially or occupationally (eg parent or childcare worker). This applies only to female participants 20 years of age or above.
For more information about the study, call the study research nurse Jo Chambers on 03 42152880 or email [email protected]
This clinical trial has been approved by Monash Human Research Ethics Committee
Victorian Cancer Trials
New clinical trial to prevent Urinary Tract Infections (UTIs)
Barwon Health is currently looking for participants for a clinical trial to prevent Urinary tract infections (UTIs)
Participants would be required to attend several visits over a 3 year period.
You may be eligible if you are:
- Adults aged ≥ 60 years
- Have a history of UTI in the past 2 years
- In generally good health
For more information please call 03 4215 2877 or email [email protected]
This study has been approved by Monash Human Research Ethics Committee
New vaccine trial for staph aureus – soft skin infections
Barwon Health is currently looking for volunteers who have had a recent staph aureus infection to participate in a research study.
The aim of the study is to trial a new vaccine to prevent re-infection of staph aureus
To be eligible you must:
- Be aged 18 - 64
- Have a recent or current soft skin infection caused by staph aureus
- Be generally healthy
If you are interested in finding out more, please contact Anne Welsh, Research Nurse on 0421 063 393 or [email protected]
Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome (ME/CFS) Study
This NHMRC study is a joint venture between Deakin University and Barwon Health that aims to improve the understanding of the disorder as well as to look for new treatments for ME/CFS.
Who can participate?
- Individuals with a diagnosis of ME/CFS
- Individuals with no known disease (healthy controls)
- Male or female, 18-65 years old
- Not currently pregnant
- Not currently enrolled in a clinical trial
Key points for participants
- The study will not involve any costs
- Once enrolled in the study, you will receive a gift voucher up to $40 for any travel costs
- No additional treatment will be provided
- Surveys will be done online at your own pace
- Only ONE appointment needed to take part
- Study involves donating a blood sample
For more information
Weight loss study seeking night shift workers
Do you work at least four night shifts every fortnight, and want to lose weight?
We are seeking participants for a world-first study (SWIFt), which will compare different types of diets to help with weight loss & improve overall health for shift workers.
Over 18 months, you will:
- be given a dietary weight loss program to follow for 24 weeks
- consult with a dietitian regularly and be provided with study foods for 24 weeks
- after this period, be followed up for one year to monitor your progress
- have your body measurements taken throughout the study
HOW WILL I BENEFIT?
By volunteering for this study, you’re helping our researchers find a suitable diet plan that meets the needs of night shift workers.
The outcomes of SWIFt could result in new dietary recommendations that improve the health of night shift workers throughout Australia – and you’ll be playing a key role in helping us get there.
Participants will receive a $100 petrol voucher and be provided some study meals.
To find out more or to enrol now, please visit the SWIFt study website or scan the QR code
This study has been approved by Barwon Health Human Research Ethics Committee.
Whipple's Disease Study - healthy volunteers required
Whipple’s Disease is a rare but very serious infection which is due to a very common environmental bacterium. We suspect that many people are exposed to this bacterium but only very few become infected, for reasons not well understood. The bacterium is ingested with food and water and excreted in their faeces. Normal people produce antibodies to it.
We are asking healthy volunteers to:
1. Provide a saliva sample, as the mouth is the route of entry of this bacterium to the body.
2. Provide a faecal sample, as the bacterium is excreted from the body by this route. You will be given an empty container to place in your toilet and into which you will easily be able to collect some faeces. The container will come with a tightly fitting lid for safe transport to the lab.
3. Provide a blood sample, from which we will measure your level of antibodies to the bacterium.
For those who are interested to help out for this study, please contact Dr K.C Liew, Principal Investigator, on 0433 186 662 or [email protected]. Your time and effort for this study will be truly appreciated.
The Barwon Health Cardiology Unit is conducting a clinical trial with men (50 years old and older) and women (55 years old and older), who are taking medication to lower their cholesterol and who are at risk of a cardiovascular event, like heart attack and stroke.
The purpose of this research is to find out whether an investigational medication may reduce the risk of cardiovascular events, like heart attack and stroke, in people at high risk for these events.
For more information, please call Donna Soraghan on 4215 1032
The research is being conducted by Associate Prof John Amerena at the University Hospital Geelong
All calls will be treated with the strictest confidence. This research study has been approved by the Monash Health Human Research Ethics Committee.
Last Modified: Thursday, 17 November 2022